FDA and EMA review Biogen's higher dose SMA drug
CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...
Vancouver25m
B.C.’s AI investment climate remains strong as sector develops
Events and conferences continue to connect Vancouver-based researchers with investors, as governments move money into ...
PathAI inc: PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions
Collaboration Marks First At-Scale Deployment of AI Technologies into Leading Commercial BiobankBOSTON and HUNTSVILLE, Ala, Jan. 23, 2025, a leading biospecimens and specialty lab testing company, to ...